NCT00001570View on ClinicalTrials.gov

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 28, 1997

Study Completion Date

January 31, 2001

Conditions
Kidney NeoplasmsNeoplasm Metastasis
Interventions
DRUG

PSC 833

DRUG

vinblastine

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH